GM-CSF have been reported toreduce the severity of lung injury,28 chemical and hemorrhagic acute lung injury29 and the severity of bacterial lunginfection.30 In addition,deficiencies in GM-CSF have been linked to more severe fibrosis outcomes inbleomycin-induced pulmonary fibrosis models.31,32. This evidence concerns the gene CSF2 and pulmonary fibrosis.